The Patent Finder

Compounds for the Treatment of Diseases Linked to Mitochondrial Reactive Oxygen Species (ROS) Production

Universite de Bordeaux

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/EP2016/071170, filed Sep 8, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,272,066Compounds for the Treatment of Diseases Linked to Mitochondrial Reactive Oxygen Species (ROS) Production
In force
 · High confidence
UsedRemaining
OP2 Drugs, Centre Hospitalier Universitaire de Bordeaux, Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de BordeauxIn forceHigh confidence
US 10,653,668Compounds for the Treatment of Diseases Linked to Mitochondrial Reactive Oxygen Species (ROS) Production
In force
 · High confidence
OP2 Drugs, Centre Hospitalier Universitaire de Bourdeaux, Inserm (Institut National de la Sante et de la Recherche Medicale) and Universite de BordeauxIn forceHigh confidence
US 11,318,113Compounds for the Treatment of Diseases Linked to Mitochondrial Reactive Oxygen Species (ROS) Production
In force
 · High confidence
Centre Hospitalier Universitaire de BordeauxIn forceHigh confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited